Priyankar Pal1, Prabhas Prasun Giri2, Rajiv Sinha3. 1. Department of Pediatrics, Pediatric Rheumatology Unit, Institute of Child Health, 11, Dr Biresh Guha Street, Kolkata, West Bengal, 700017, India. mailme.priyankar@gmail.com. 2. Department of Pediatrics, Institute of Child Health, Kolkata, West Bengal, India. 3. Pediatric Nephrology Unit, Department of Pediatrics, Institute of Child Health, Kolkata, West Bengal, India.
Abstract
OBJECTIVES: To assess the efficacy of cyclosporine (CsA) in patients of oral steroid unresponsive or steroid dependent systemic juvenile idiopathic arthritis (sJIA); to evaluate the optimum dosage and blood level of CsA to achieve and maintain remission and to observe for side-effects on prolonged usage. METHODS: This prospective observational study was conducted on children with steroid dependent /refractory sJIA admitted at the Institute of Child Health, Kolkata from July 2009 through November 2014. A total of 82 sJIA was diagnosed; 15 were steroid dependent /refractory and were included as candidates for cyclosporine therapy. RESULTS: CsA was used in 15 patients; 13 showed a favourable response with significant steroid sparing effect and minimal toxicity. CONCLUSION: CsA was found to be effective in almost 75% of frequently relapsing steroid dependent sJIA to achieve and maintain remission. The average cost of therapy for a 20 kg patient on CsA was found to be 10,000 INR (132 EURO)/ patient over a 6 mo period; which would amount to 100,000 INR (1318 EURO)/patient with Tocilizumab for the same duration.
OBJECTIVES: To assess the efficacy of cyclosporine (CsA) in patients of oral steroid unresponsive or steroid dependent systemic juvenile idiopathic arthritis (sJIA); to evaluate the optimum dosage and blood level of CsA to achieve and maintain remission and to observe for side-effects on prolonged usage. METHODS: This prospective observational study was conducted on children with steroid dependent /refractory sJIA admitted at the Institute of Child Health, Kolkata from July 2009 through November 2014. A total of 82 sJIA was diagnosed; 15 were steroid dependent /refractory and were included as candidates for cyclosporine therapy. RESULTS:CsA was used in 15 patients; 13 showed a favourable response with significant steroid sparing effect and minimal toxicity. CONCLUSION:CsA was found to be effective in almost 75% of frequently relapsing steroid dependent sJIA to achieve and maintain remission. The average cost of therapy for a 20 kg patient on CsA was found to be 10,000 INR (132 EURO)/ patient over a 6 mo period; which would amount to 100,000 INR (1318 EURO)/patient with Tocilizumab for the same duration.
Authors: N Ruperto; A Ravelli; E Castell; V Gerloni; R Haefner; C Malattia; F Kanakoudi-Tsakalidou; S Nielsen; J Bohnsack; D Gibbas; R Rennebohm; O Voygioyka; Z Balogh; L Lepore; E Macejkova; N Wulffraat; S Oliveira; R Russo; A Buoncompagni; M O Hilário; M G Alpigiani; M Passo; D J Lovell; R Merino; A Martini; E H Giannini Journal: Clin Exp Rheumatol Date: 2006 Sep-Oct Impact factor: 4.473
Authors: Fabrizio De Benedetti; Hermine I Brunner; Nicolino Ruperto; Andrew Kenwright; Stephen Wright; Inmaculada Calvo; Ruben Cuttica; Angelo Ravelli; Rayfel Schneider; Patricia Woo; Carine Wouters; Ricardo Xavier; Lawrence Zemel; Eileen Baildam; Ruben Burgos-Vargas; Pavla Dolezalova; Stella M Garay; Rosa Merino; Rik Joos; Alexei Grom; Nico Wulffraat; Zbigniew Zuber; Francesco Zulian; Daniel Lovell; Alberto Martini Journal: N Engl J Med Date: 2012-12-20 Impact factor: 91.245
Authors: A Ravelli; C Moretti; F Temporini; F Rossi; S Magni-Manzoni; A Pistorio; A Martini Journal: Clin Exp Rheumatol Date: 2002 Jul-Aug Impact factor: 4.473
Authors: P Tugwell; T Pincus; D Yocum; M Stein; O Gluck; G Kraag; R McKendry; J Tesser; P Baker; G Wells Journal: N Engl J Med Date: 1995-07-20 Impact factor: 91.245
Authors: Giuseppe Caruso; Anna Privitera; Barbara Moura Antunes; Giuseppe Lazzarino; Susan Marie Lunte; Giancarlo Aldini; Filippo Caraci Journal: Molecules Date: 2022-07-12 Impact factor: 4.927